Tango Therapeutics (TNGX) Stock Price, Quote, News & History | Benzinga

Tango Therapeutics Inc (TNGX) Stock Price, Quote, News & History

TNGXNASDAQ

Trade with Public

Trade with Public

$26.26

-0.08-0.3%

Last update: Aug 12, 12:50 PM

Earnings: Q2 2026 Earnings were released on Tue Aug 11th, before the market open

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$26.08

Close

-

Volume / Avg.

941.61K / 3.91M

Day Range

$25.64 - $26.84

52 Wk Range

6.25 - 34.39

Market Cap

$4.43B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

26.75%

Days to Cover

19.15

Recent Tango Therapeutics, Inc. News

This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Wall Street analysts initiated coverage on various top stocks, including VCYT, UMAC, FISN, LTRX, and TNGX with positive ratings and price targets.

Avi Kapoor

Apple, SUNation Energy, Tango Therapeutics, Applied Digital And Cerebras Systems: Why These 5 Stocks Are On Investors' Radars Today

AAPL, SUNE, TNGX, APLD, CBRS were among the stocks seen trending on Monday, June 8, 2026.

Shivdeep Dhaliwal

Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings

US stocks rose with Nasdaq up 400 points. Dow up 0.32%, Nasdaq up 1.55%, S&P 500 up 0.94%. Tech shares rose, communication services fell. Motorcar Parts of America stock jumped 37% on strong earnings. Sunation Energy and Suniva announced merger agreement. Oil up, gold and silver down. European and Asian markets closed lower.

Avi Kapoor

Tango Therapeutics, American Battery Technology, Intel And Other Big Stocks Moving Higher On Monday

U.S. stocks higher, Nasdaq Composite up 1%. Tango Therapeutics (TNGX) shares up 34.1% on positive trial data. Other big gainers include ENHA, JLHL, ABAT, BTGO, GLXY, CLYM, SOC, SRAD, AIAI, ALOY, and GENI.

Avi Kapoor

Why Is Tango Therapeutics Stock Soaring Monday?

Tango Therapeutics reports 90% 6-month PFS in pancreatic cancer trial. Read about the vopimetostat combo driving TNGX stock up.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-143.90M

Investing Cash Flow (TTM)

-524.58M

Financing Cash Flow (TTM)

974.33M

Free Cash Flow (TTM)

-144.27M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

305.86M

Analyst Trends and Forecast

2

Apr

3

1

May

6

Jun

2

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.46B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

66.15

PB Ratio (TTM)

4.33

Earnings Yield % (TTM)

-3.19%

Earnings Yield % (FWD)

-4.65%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$6.08

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$345.56M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$26.08

Close

-

Volume / Avg.

941.61K / 3.91M

Day Range

$25.64 - $26.84

52 Wk Range

6.25 - 34.39

Market Cap

$4.43B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

26.75%

Days to Cover

19.15

About

Sector

Health Care

Industry

Biotechnology

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing pre...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Tango Therapeutics (TNGX) stock?

A

You can purchase shares of Tango Therapeutics (NASDAQ:TNGX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Tango Therapeutics (TNGX) competitors?

A

Other companies in Tango Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Tango Therapeutics (TNGX) stock?

A

Tango Therapeutics has a consensus price target of $36.86.

Q

What is the current price for Tango Therapeutics (TNGX)?

A

The stock price for Tango Therapeutics (NASDAQ: TNGX) is $26.26 last updated August 12, 2026 at 12:50 PM EDT.

Q

Does Tango Therapeutics (TNGX) pay a dividend?

A

There are no upcoming dividends for Tango Therapeutics.

Q

When is Tango Therapeutics (NASDAQ:TNGX) reporting earnings?

A

Tango Therapeutics does not have any upcoming earnings scheduled.

Q

Is Tango Therapeutics (TNGX) going to split?

A

There is no upcoming split for Tango Therapeutics.

Q

What sector and industry does Tango Therapeutics (TNGX) operate in?

A

Tango Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.